COMBIVIR Safety Questions, COMBIVIR Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about COMBIVIR. Our extensive database of COMBIVIR adverse events and COMBIVIR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about COMBIVIR

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




COMBIVIR Safety Reports

Total COMBIVIR reports: 377.
COMBIVIR FDA safety alerts: 2002 2007 .
Reported deaths: 26    Reported hospitalizations: 109.
Take COMBIVIR Side Effects Survey or Share Your COMBIVIR Story. COMBIVIR Usage.

Showing 1-75 of 377 Next >

Health Professional from UNITED STATES reported COMBIVIR problem on Mar 14, 2007. Male patient, weighting 5.07 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: hydronephrosis, kidney malformation, renal disorder. COMBIVIR dosage: unknown. During the same period patient was treated with VIRACEPT. Patient recovered.

COMBIVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 37 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: normal newborn, placenta praevia, premature separation of placenta. COMBIVIR dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, RITONAVIR, TENOFOVIR DISOPROXIL FUMARATE, KALETRA. Patient recovered.

Physician from UNITED KINGDOM reported COMBIVIR problem on Mar 12, 2007. Female patient, 36 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: genital ulceration, hypersensitivity, leukocytoclastic vasculitis, mouth ulceration, stevens-johnson syndrome. COMBIVIR dosage: unknown. Patient was hospitalized. Patient recovered.

COMBIVIR problem was reported by a Physician from BOTSWANA on Mar 15, 2007. Female patient, 31 years of age, weighting 211.6 lb, was diagnosed with antiviral prophylaxis and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, oedema, pre-eclampsia, proteinuria, weight increased. COMBIVIR dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported COMBIVIR problem on Mar 20, 2007. Female patient, weighting 11.02 lb, was diagnosed with hiv infection, retroviral infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: metabolic acidosis, methylmalonic aciduria, underweight, vitamin b12 deficiency. COMBIVIR dosage: unknown. During the same period patient was treated with VIRAMUNE, ZIDOVUDINE. Patient was hospitalized. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Female patient, 36 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: alpha 1 foetoprotein abnormal, stillbirth. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with VIRACEPT. Patient recovered.

Health Professional from GERMANY reported COMBIVIR problem on Mar 23, 2007. Female patient, 36 years of age, was diagnosed with systemic antiviral treatment and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, caesarean section, diarrhoea, diarrhoea haemorrhagic, normal delivery, pregnancy, pseudomembranous colitis. COMBIVIR dosage: unknown. During the same period patient was treated with TELZIR, KALETRA, NORVIR, COTRIM. Patient was hospitalized. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Female patient, weighting 2.87 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, congenital heart valve disorder, patent ductus arteriosus, pulmonary hypertension, tricuspid valve incompetence, ventricular hypertrophy. COMBIVIR dosage: unknown. During the same period patient was treated with VIRACEPT. Patient was hospitalized. Patient died on 05/31/2006.

Health Professional from UNITED STATES reported COMBIVIR problem on Apr 05, 2007. Female patient, weighting 6.83 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: adrenogenital syndrome, aneurysm, atrial septal defect, bronchiolitis, bundle branch block right, cardiac murmur, cardiomegaly, dilatation atrial. COMBIVIR dosage: unknown. During the same period patient was treated with VIRACEPT, TRIMETHOPRIM. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UNITED STATES on Apr 05, 2007. Male patient, weighting 6.39 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, patent ductus arteriosus, trisomy 21. COMBIVIR dosage: unknown. During the same period patient was treated with TRIZIVIR, RETROVIR. Patient recovered.

Health Professional from BOTSWANA reported COMBIVIR problem on Apr 05, 2007. Female patient, 32 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: unknown. During the same period patient was treated with VIRAMUNE. Patient recovered.

COMBIVIR problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 10, 2007. Female patient, weighting 11.02 lb, was diagnosed with hiv infection, retroviral infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, metabolic acidosis, methylmalonic aciduria, rhinitis, underweight, vitamin b12 deficiency. COMBIVIR dosage: unknown. During the same period patient was treated with VIRAMUNE, ZIDOVUDINE. Patient was hospitalized. Patient recovered.

Physician from ZIMBABWE reported COMBIVIR problem on Apr 10, 2007. Female patient, 41 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac failure congestive, congestive cardiomyopathy, cough, dilatation atrial, dilatation ventricular, dyspnoea, dyspnoea exertional, mitral valve calcification. COMBIVIR dosage: unknown. During the same period patient was treated with TENOFOVIR. Patient recovered.

COMBIVIR problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 10, 2007. Female patient, weighting 11.02 lb, was diagnosed with hiv infection, retroviral infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: metabolic acidosis, methylmalonic aciduria, underweight, vitamin b12 deficiency. COMBIVIR dosage: unknown. During the same period patient was treated with VIRAMUNE, ZIDOVUDINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported COMBIVIR problem on Apr 05, 2007. Female patient, 27 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. COMBIVIR dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UNITED KINGDOM on Apr 10, 2007. Female patient was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: ascites, hydrops foetalis, pericardial effusion, ultrasound antenatal screen abnormal. COMBIVIR dosage: unknown. During the same period patient was treated with VIRAMUNE. Patient recovered.

Physician from BOTSWANA reported COMBIVIR problem on Apr 12, 2007. Male patient, child 0 years of age, was diagnosed with antiviral prophylaxis and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: cyanosis, grunting, respiratory distress. COMBIVIR dosage: unknown. During the same period patient was treated with KALETRA, ZIDOVUDINE, NEVIRAPINE. Patient recovered.

COMBIVIR problem was reported by a Physician from UNITED STATES on Apr 05, 2007. Male patient, weighting 5.10 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: constipation, hydroureter, kidney malformation, nephrotic syndrome. COMBIVIR dosage: unknown. During the same period patient was treated with NELFINAVIR MESYLATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVIR problem on Apr 16, 2007. Female patient, 33 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: brain neoplasm. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with NELFINAVIR. Patient recovered.

COMBIVIR problem was reported by a Physician from ZIMBABWE on Apr 17, 2007. Female patient, 41 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac failure congestive, congestive cardiomyopathy, cough, dilatation atrial, dilatation ventricular, dyspnoea, dyspnoea exertional, mitral valve calcification. COMBIVIR dosage: unknown. During the same period patient was treated with TENOFOVIR. Patient recovered.

Physician from KENYA reported COMBIVIR problem on Apr 12, 2007. Female patient, 24 years of age, weighting 110.9 lb, was diagnosed with antiviral prophylaxis and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: headache, hepatotoxicity, jaundice. COMBIVIR dosage: unknown. During the same period patient was treated with NELFINAVIR. Patient recovered.

COMBIVIR problem was reported by a Consumer or non-health professional from FRANCE on Apr 12, 2007. Female patient, child 4 years of age, weighting 47.62 lb, was diagnosed with antiviral prophylaxis and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute lymphocytic leukaemia, asthenia, blood fibrinogen increased, blood sodium decreased, c-reactive protein increased, diarrhoea, ecchymosis. COMBIVIR dosage: unknown. During the same period patient was treated with RETROVIR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COMBIVIR problem on Apr 17, 2007. Male patient was diagnosed with antiviral prophylaxis and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: depression, fatigue, lethargy, rectal haemorrhage, umbilical hernia, vomiting, weight increased. COMBIVIR dosage: unknown. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UNITED STATES on Apr 20, 2007. Female patient, 28 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: unknown. During the same period patient was treated with NORVIR, SAQUINAVIR. Patient recovered.

Physician from UNITED STATES reported COMBIVIR problem on Apr 20, 2007. Female patient was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: cerebral ventricle dilatation, spina bifida. COMBIVIR dosage: unknown. During the same period patient was treated with ATRIPLA, VIRACEPT, ALCOHOL, TOBACCO. Patient recovered.

COMBIVIR problem was reported by a Physician from BOTSWANA on Apr 17, 2007. Male patient, weighting 5.51 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: neutropenia. COMBIVIR dosage: unknown. During the same period patient was treated with ZIDOVUDINE, NEVIRAPINE, AMPICILLIN. Patient recovered.

Health Professional from BOTSWANA reported COMBIVIR problem on Apr 13, 2007. Female patient, 38 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion induced. COMBIVIR dosage: unknown. During the same period patient was treated with VIRAMUNE, STOCRIN. Patient recovered.

COMBIVIR problem was reported by a Physician from BOTSWANA on Apr 23, 2007. Female patient, 31 years of age, weighting 211.6 lb, was diagnosed with antiviral prophylaxis and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, oedema, pre-eclampsia, proteinuria, weight increased. COMBIVIR dosage: unknown. During the same period patient was treated with KALETRA. Patient died.

Physician from ESTONIA reported COMBIVIR problem on Apr 25, 2007. Male patient, 31 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia, thrombocytopenic purpura. COMBIVIR dosage: unknown. During the same period patient was treated with STOCRIN, EPIVIR. Patient was hospitalized. Patient recovered.

COMBIVIR problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 27, 2007. Male patient was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal hernia, cardiac murmur, congenital anomaly, cryptorchism. COMBIVIR dosage: 600MG PER DAY. During the same period patient was treated with TRUVADA, VIRACEPT, KALETRA, RETROVIR, FOLIC ACID. Patient recovered.

Health Professional from UNITED STATES reported COMBIVIR problem on Apr 27, 2007. Male patient, weighting 5.95 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: cystic fibrosis. COMBIVIR dosage: unknown. During the same period patient was treated with NEVIRAPINE, KALETRA. Patient recovered.

COMBIVIR problem was reported by a Consumer or non-health professional from FRANCE on Apr 25, 2007. Male patient, 43 years of age, weighting 180.8 lb, was diagnosed with hiv infection, hepatitis c and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, ascites, blood alkaline phosphatase increased, blood bilirubin increased, hepatic cirrhosis, macrocytosis, neutropenia, pneumococcal sepsis, prothrombin level decreased. COMBIVIR dosage: unknown. During the same period patient was treated with NORVIR, REYATAZ, AMOXICILLIN, REBETOL, PEGASYS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported COMBIVIR problem on May 04, 2007. Male patient, weighting 1.10 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: premature baby. COMBIVIR dosage: unknown. During the same period patient was treated with ZIDOVUDINE, NELFINAVIR. Patient recovered.

COMBIVIR problem was reported by a Health Professional from GERMANY on Apr 30, 2007. Male patient, weighting 6.17 lb, was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, diaphragmatic hernia, pregnancy. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with EPIVIR, VIREAD, NORVIR, FUZEON, INVIRASE. Patient recovered.

Health Professional from UNITED KINGDOM reported COMBIVIR problem on May 04, 2007. Female patient was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: ascites, cardiomyopathy, cytomegalovirus infection, developmental delay, hydrops foetalis, pericardial effusion, ultrasound antenatal screen abnormal. COMBIVIR dosage: unknown. During the same period patient was treated with VIRAMUNE. Patient recovered.

COMBIVIR problem was reported by a Consumer or non-health professional from FRANCE on May 03, 2007. Male patient, 72 years of age, weighting 132.3 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: asthenia, chromaturia, condition aggravated, faeces discoloured, hepatitis, jaundice, oedema peripheral, somnolence. COMBIVIR dosage: unknown. During the same period patient was treated with RETROVIR, TARKA, INDAPAMIDE, ASPEGIC. Patient was hospitalized. Patient died on 04/10/2007.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 28 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. COMBIVIR dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Physician from UNITED KINGDOM on May 07, 2007. Female patient was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, renal disorder. COMBIVIR dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 37 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Consumer or non-health professional from SWEDEN on May 03, 2007. Female patient, 21 years of age, was diagnosed with antiviral prophylaxis and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: unknown. During the same period patient was treated with KALETRA. Patient was hospitalized. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 35 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 32 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 33 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 38 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 35 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 40 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 20 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: stillbirth. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with NEVIRAPINE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 30 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 35 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 38 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: stillbirth. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 39 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: stillbirth. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 33 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with NEVIRAPINE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with NEVIRAPINE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 32 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with NEVIRAPINE. Patient recovered.

Health Professional from UNITED STATES reported COMBIVIR problem on May 15, 2007. Female patient, weighting 6.83 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: adrenogenital syndrome, aneurysm, atrial septal defect, bronchiolitis, bundle branch block right, cardiac murmur, cardiomegaly, ebstein's anomaly. COMBIVIR dosage: unknown. During the same period patient was treated with VIRACEPT, TRIMETHOPRIM. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 27 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with NEVIRAPINE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 37 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: stillbirth. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 30 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: stillbirth. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with NEVIRAPINE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 36 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 32 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 38 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 36 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 36 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, 33 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UNITED STATES reported COMBIVIR problem on May 17, 2007. Female patient, weighting 6.83 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: adrenogenital syndrome, aneurysm, atrial septal defect, bronchiolitis, bundle branch block right, cardiac murmur, cardiomegaly, constipation, diarrhoea. COMBIVIR dosage: unknown. During the same period patient was treated with VIRACEPT, TRIMETHOPRIM. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 08, 2007. Female patient, weighting 7.50 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: acrochordon. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UGANDA reported COMBIVIR problem on May 08, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

COMBIVIR problem was reported by a Health Professional from UGANDA on May 09, 2007. Female patient, weighting 5.73 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: talipes. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with NEVIRAPINE. Patient recovered.

Health Professional from UNITED STATES reported COMBIVIR problem on May 18, 2007. Male patient, weighting 6.83 lb, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: trisomy 21. COMBIVIR dosage: unknown. During the same period patient was treated with ZIDOVUDINE, NELFINAVIR. Patient recovered.

COMBIVIR problem was reported by a Physician from SOUTH AFRICA on May 17, 2007. Female patient, 53 years of age, weighting 183.0 lb, was diagnosed with hiv infection, genital herpes and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: anorexia, chest pain, diffuse large b-cell lymphoma, dyspnoea, fatigue, lymphadenopathy, night sweats, oedema peripheral, pain in extremity. COMBIVIR dosage: unknown. During the same period patient was treated with ACYCLOVIR, HYDROCHLOROTHIAZIDE, ATENOLOL. Patient was hospitalized. Patient died on 04/15/2007.

Consumer or non-health professional from UNITED KINGDOM reported COMBIVIR problem on May 15, 2007. Female patient, 45 years of age, weighting 172.0 lb, was diagnosed with antiviral prophylaxis, hypothyroidism and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, liver function test abnormal, nausea. COMBIVIR dosage: unknown. During the same period patient was treated with NELFINAVIR, LEVOTHYROXINE. Patient recovered.

COMBIVIR problem was reported by a Physician from UNITED STATES on May 08, 2007. Female patient was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: congenital choroid plexus cyst. COMBIVIR dosage: 900MG PER DAY. During the same period patient was treated with NELFINAVIR. Patient recovered.

Health Professional from UNITED STATES reported COMBIVIR problem on May 22, 2007. Female patient, 46 years of age, was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: abdominal distension, diarrhoea, gastritis haemorrhagic, pain. COMBIVIR dosage: unknown. During the same period patient was treated with VIREAD, NEURONTIN, ZOLOFT. Patient recovered.

COMBIVIR problem was reported by a Physician from UNITED KINGDOM on May 16, 2007. Female patient was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, renal disorder. COMBIVIR dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.

Physician from UNITED KINGDOM reported COMBIVIR problem on May 17, 2007. Female patient, 52 years of age, was diagnosed with hiv infection and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: nephrolithiasis. COMBIVIR dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, FOSAMPRENAVIR, RITONAVIR, KALETRA. Patient recovered.

Showing 1-75 of 377 Next >

Ask Our Patient Community about COMBIVIR

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert